omniture
logo
Search
SK bioscience
Media Room

Photo News

rss
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access

SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access

2026-06-02 20:00 1657
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund

SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund

2026-05-29 20:00 2696
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America

SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America

2026-05-26 20:00 3572
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

2026-03-18 20:00 5522
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

2026-01-29 10:10 7055
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

2026-01-22 21:00 7607
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

2025-11-05 21:00 3393
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

2025-10-15 20:00 3867
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

2025-09-02 19:00 3579
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

2025-08-21 20:00 3054
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

2025-05-21 20:00 3283
SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

2025-05-06 20:00 3125
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

2025-02-25 21:00 3655
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

2024-12-12 21:00 3599
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

2024-10-23 20:00 3702
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

2024-10-23 15:11 3233
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

2024-10-08 20:00 2842
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika

South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika

2024-10-02 20:00 3948
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market

SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market

2024-03-21 13:24 4207
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum

SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum

2023-05-23 20:00 2980
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center

SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center

2023-02-08 20:00 3019
12